{"id":5570,"date":"2022-08-01T03:40:18","date_gmt":"2022-08-01T03:40:18","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=5570"},"modified":"2023-08-29T17:55:03","modified_gmt":"2023-08-29T17:55:03","slug":"pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=5570","title":{"rendered":"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8"},"content":{"rendered":"

PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002<\/p>\n

\u4f4d\u4e8e\u73c0\u65af\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u6280\u672f\u4e13\u6ce8\u4e8e\u5c06\u836f\u7269 MPL \u91cd\u65b0\u7528\u4e8e\u4eba\u7c7b\u548c\u52a8\u7269\u7684\u591a\u79cd\u9776\u5411\u6cbb\u7597\uff0c\u51e0\u9879\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u4e8e 2023 \u8d22\u5e74\u5f00\u59cb\u3002<\/p>\n

MPL \u662f\u54fa\u4e73\u52a8\u7269\u96f7\u5e15\u9709\u7d20\u9776\u86cb\u767d (mTOR) \u901a\u8def\u7684\u65b0\u578b\u3001\u5f3a\u6548\u548c\u65e0\u6bd2\u6291\u5236\u5242\uff0c\u5b83\u662f\u5f71\u54cd\u764c\u75c7\u751f\u957f\u3001\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u751a\u81f3\u75c5\u6bd2\u6d3b\u6027\u7684\u5173\u952e\u3002<\/p>\n

\u5168\u7403 mTOR \u6291\u5236\u5242\u76ee\u524d\u6bcf\u5e74\u8d85\u8fc7 25 \u4ebf\u7f8e\u5143\uff0835.7 \u4ebf\u6fb3\u5143\uff09\uff0cPharmAust \u7684\u76ee\u6807\u662f\u5728\u672a\u6765 MPL \u5728\u517d\u533b\u764c\u75c7\u548c\u4eba\u7c7b\u764c\u75c7\u4e2d\u7684\u5e94\u7528\u4e2d\u83b7\u5229\u3002<\/p>\n

\u4e0e\u5316\u7597\u548c\u96f7\u5e15\u9709\u7d20\u66ff\u4ee3\u54c1\u4e0d\u540c\uff0cMPL \u5177\u6709\u65e0\u6bd2\u7279\u6027\uff0c\u53ef\u4fdd\u62a4\u4e2a\u4f53\u7684\u514d\u75ab\u7cfb\u7edf\u514d\u53d7\u7834\u574f\uff0c\u5141\u8bb8\u9ad8 MPL \u5242\u91cf\uff0c\u4ece\u800c\u5e26\u6765\u66f4\u597d\u7684\u751f\u6d3b\u8d28\u91cf\u524d\u666f\u3002<\/p>\n

PharmAust \u58f0\u79f0\uff0c\u5b83\u7684\u6297\u764c\u7279\u6027\u8fd8\u63d0\u51fa\u4e86\u4e00\u79cd\u66f4\u4fbf\u5b9c\u4e14\u5408\u4e4e\u9053\u5fb7\u7684\u72ac\u7c7b\u5316\u7597\u66ff\u4ee3\u65b9\u6848\uff0c\u8be5\u516c\u53f8\u8fc4\u4eca\u4e3a\u6b62\u7684 2 \u671f\u8bd5\u9a8c\u6570\u636e\u8bc1\u660e\u4e86\u8fd9\u4e00\u70b9\u3002<\/p>\n

\u91cd\u65b0\u5229\u7528 MPL<\/h2>\n

\u867d\u7136\u5316\u5b66\u7597\u6cd5\u4e00\u76f4\u662f\u5bf9\u6297\u764c\u75c7\u7684\u4f20\u7edf\u65b9\u6cd5\uff0c\u4f46\u5b83\u4e5f\u9488\u5bf9\u6b63\u5e38\u7684\u5065\u5eb7\u7ec6\u80de\uff0c\u540c\u65f6\u8bd5\u56fe\u5bf9\u6297\u6709\u5bb3\u7ec6\u80de\uff0c\u635f\u5bb3\u4eba\u4f53\u7684\u514d\u75ab\u7cfb\u7edf\u3002<\/p>\n

\u56e0\u6b64\uff0c\u5c3d\u7ba1 mTOR \u6291\u5236\u5242\u53ef\u6709\u6548\u9632\u6b62\u764c\u7ec6\u80de\u751f\u957f\u548c\u589e\u6b96\uff0c\u4f46\u5b83\u4eec\u53ef\u4ee5\u4e0e\u764c\u75c7\u540c\u65f6\u653b\u51fb\u5065\u5eb7\u7ec4\u7ec7\u3002<\/p>\n

PharmAust \u8868\u793a\uff0cMPL \u53ef\u4ee5\u4f5c\u4e3a\u4e00\u79cd\u5173\u952e\u7684\u6297\u764c\u7597\u6cd5\uff0c\u5728\u8f83\u957f\u65f6\u95f4\u5185\u5b89\u5168\u5730\u6291\u5236\u9776\u5411\u764c\u75c7\uff0c\u5e76\u5e26\u6765\u826f\u597d\u7684\u751f\u6d3b\u8d28\u91cf\u3002<\/p>\n

MPL \u8fd8\u4fc3\u8fdb\u81ea\u566c\uff0c\u8fd9\u6709\u52a9\u4e8e\u4fdd\u62a4\u8eab\u4f53\u7684\u5065\u5eb7\u7ec6\u80de\uff0c\u5305\u62ec\u6e05\u9664\u5782\u6b7b\u7684\u764c\u7ec6\u80de\u3002<\/p>\n

MPL \u5177\u6709\u51e0\u4e4e\u5b8c\u5168\u65e0\u6bd2\u7684\u6027\u8d28\uff0c\u4e0e\u73b0\u6709\u7684\u80bf\u7624\u5b66\u76f8\u6bd4\u5177\u6709\u663e\u7740\u4f18\u52bf\uff0c\u5e76\u63d0\u4f9b\u795e\u7ecf\u9000\u884c\u6027\u7597\u6cd5\u3002<\/p>\n

\u4f5c\u4e3a\u4e00\u79cd\u518d\u5229\u7528\u836f\u7269\uff0cMPL \u76ee\u524d\u5df2\u5728 38 \u4e2a\u56fd\u5bb6\u6ce8\u518c\uff0c\u5e76\u83b7\u5f97\u4e86\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40 (TGA) \u7684\u6279\u51c6\u3002<\/p>\n

\u518d\u5229\u7528\u836f\u7269\u63a7\u5236\u7740\u517d\u533b\u5e02\u573a\uff0c\u5e76\u4e14\u7531\u4e8e\u4e0e\u5176\u4ed6\u836f\u7269\u76f8\u6bd4\u5177\u6709\u6210\u672c\u548c\u65f6\u95f4\u6548\u76ca\uff0c\u56e0\u6b64\u5728\u4eba\u7c7b\u4ea7\u54c1\u4e2d\u8d8a\u6765\u8d8a\u53d7\u6b22\u8fce\u3002<\/p>\n

MPL \u4f5c\u4e3a\u4e00\u79cd\u91cd\u65b0\u5229\u7528\u7684\u836f\u7269\u6709\u7740\u79ef\u6781\u7684\u5386\u53f2\uff0c\u901a\u8fc7\u4e34\u5e8a\u8bd5\u9a8c\u5728\u4eba\u7c7b\u548c\u52a8\u7269\u4e2d\u901a\u8fc7 Zolvix\u3002<\/p>\n

MPL \u72ac\u764c\u6cbb\u7597<\/h2>\n

\u7531\u4e8e\u76f8\u4f3c\u7684\u57fa\u56e0\u7cfb\u7edf\uff0c\u72ac\u7c7b\u60a3\u6709\u8bb8\u591a\u4e0e\u4eba\u7c7b\u76f8\u540c\u7684\u764c\u75c7\u3002<\/p>\n

MPL \u5728 38 \u4e2a\u56fd\u5bb6\u6ce8\u518c\u7528\u4e8e\u52a8\u7269\u3002<\/p>\n

PharmAust \u5728\u60a3\u6709 B \u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u79d1\u52a8\u7269\u4e2d\u8fdb\u884c\u7684 2 \u671f\u8bd5\u9a8c\u8bc1\u660e\u4e86 MPL \u7684\u9633\u6027\u6297\u764c\u6d3b\u6027\u548c\u589e\u52a0\u7684\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u3002<\/p>\n

\u7531\u4e8e\u6709\u5e0c\u671b\u7684\u8ff9\u8c61\uff0c\u5168\u7403\u5236\u836f\u516c\u53f8\uff08\u4e5f\u79f0\u4e3a\u201c\u5927\u578b\u5236\u836f\u516c\u53f8\u201d\uff09\u5df2\u5bf9 MPL \u8bb8\u53ef\u6216\u9500\u552e\u673a\u4f1a\u8868\u73b0\u51fa\u5174\u8da3\u3002<\/p>\n

PharmAust \u7684\u72ac\u7c7b\u7814\u7a76\u7ed3\u679c\u4e5f\u5728\u56fd\u9645\u4e0a\u5f97\u5230\u8ba4\u53ef\uff0c\u82f1\u56fd\u3001\u610f\u5927\u5229\u548c\u7f8e\u56fd\u7684\u4e34\u5e8a\u5174\u8da3\u6d89\u53ca\u767d\u8840\u75c5\u3001\u80f6\u8d28\u6bcd\u7ec6\u80de\u7624\u3001\u98df\u9053\u764c\u3001\u80c3\u80a0\u764c\u3001\u5375\u5de2\u764c\u548c\u80f0\u817a\u764c\u7684 1\/2 \u671f\u4eba\u4f53\u8bd5\u9a8c\u3002<\/p>\n

MND 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u5bfc\u81f4 COVID-19 2 \u671f\u8bd5\u9a8c<\/h2>\n

MPL \u8bf1\u5bfc\u81ea\u566c\uff0c\u8fd9\u662f\u4e00\u79cd\u6e05\u9664\u4e0e\u808c\u840e\u7f29\u4fa7\u7d22\u786c\u5316\u75c7 (ALS) \u548c\u8fd0\u52a8\u795e\u7ecf\u5143\u75be\u75c5 (MND) \u75c5\u56e0\u76f8\u5173\u7684\u795e\u7ecf\u7ec6\u80de\u4e2d\u672a\u52a0\u5de5\u548c\u8fc7\u91cf\u7ec6\u80de\u5185\u86cb\u767d\u7684\u673a\u5236\u3002<\/p>\n

PharmAust \u8ba4\u4e3a MPL \u53ef\u4ee5\u901a\u8fc7\u8c03\u8282\u8fd9\u4e9b\u86cb\u767d\u8d28\u5e76\u53ef\u80fd\u51cf\u8f7b\u75c7\u72b6\u6765\u4f7f\u60a3\u8005\u7684\u795e\u7ecf\u7ec6\u80de\u53d7\u76ca\u3002<\/p>\n

\u8be5\u516c\u53f8\u7684 1 \u671f MND \u8bd5\u9a8c\u5c06\u4e3a MND \u548c COVID-19\u8bd5\u9a8c\u63d0\u4f9b\u91cd\u8981\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u6570\u636e\uff0c\u4f7f PharmAust \u80fd\u591f\u8df3\u5230 COVID-19\u7684\u4e8c\u671f\u7814\u7a76\u3002<\/p>\n

PharmAust \u5c06\u8282\u7701\u7ea6 150 \u4e07\u6fb3\u5143\uff0c\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u73b0\u5728\u5c06\u5728\u516d\u5230\u4e5d\u4e2a\u6708\u524d\u8fdb\u884c\u3002<\/p>\n

\u65e9\u5728 2020 \u5e74 4 \u6708\uff0cPharmAust \u548c\u58a8\u5c14\u672c\u7684 Walter and Eliza Hall \u533b\u5b66\u7814\u7a76\u6240\u5c31\u53d1\u73b0 MPL \u662f\u4e00\u79cd\u6f5c\u5728\u7684 COVID-19 \u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n

\u6d4b\u8bd5\u652f\u6301\u4e86\u8fd9\u4e00\u60f3\u6cd5\uff0c\u8868\u660e MPL \u548c\u83ab\u5948\u592a\u5c14\u781c (MPLS) \u6cbb\u7597\u5747\u5c06 COVID-19 \u7ec6\u80de\u95f4\u4f20\u67d3\u6027\u6291\u5236\u4e86\u7ea6 95%\u3002<\/p>\n

\u8fdb\u4e00\u6b65\u7684\u6d4b\u8bd5\u8868\u660e\uff0cMPL \u548c MPLS \u51cf\u5c11\u4e86\u75c5\u6bd2\u57f9\u517b\u57fa\u4e2d\u7684\u75c5\u6bd2\u6838\u7cd6\u6838\u9178 (RNA) \u5e76\u51cf\u5c11\u4e86\u75c5\u6bd2\u7ee7\u53d1\u611f\u67d3\u3002<\/p>\n

\u76ee\u6807\u5e02\u573a<\/h2>\n

\u5982\u679c 2 \u671f COVID-19 \u8bd5\u9a8c\u7ed3\u679c\u8bc1\u660e\u53ef\u4ee5\u9884\u9632 SARS-COV2 \u8bf1\u5bfc\u7684\u7ec6\u80de\u6b7b\u4ea1\uff0c\u90a3\u4e48\u53ef\u5bfb\u5740\u7684 COVID-19 \u5e02\u573a\u5c06\u5728 100 \u4ebf\u7f8e\u5143\u8303\u56f4\u5185\u3002<\/p>\n

\u5bf9\u4e8e\u6cbb\u7597 ALS\/MND\uff0c\u76ee\u6807\u5e02\u573a\u7ea6\u4e3a 36 \u4ebf\u7f8e\u5143\uff0c\u5229\u9c81\u5511\u7684\u5e74\u9500\u552e\u989d\u5df2\u8fbe\u5230 10 \u4ebf\u7f8e\u5143\u3002<\/p>\n

PharmAust \u5df2\u7ecf\u4e0e\u201c\u4e00\u5bb6\u9886\u5148\u7684\u5168\u7403\u5236\u836f\u516c\u53f8\u201d\u8fdb\u884c\u201c\u673a\u5bc6\u8c08\u5224\u201d\uff0c\u4ee5\u5171\u540c\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7528\u4e8e\u517d\u533b\u764c\u75c7\u7684 MPL\u3002\u5ba0\u7269\u764c\u75c7\u6cbb\u7597\u5e02\u573a\u5728 2020 \u5e74\u8d85\u8fc7 2.2 \u4ebf\u7f8e\u5143\uff0c\u9884\u8ba1\u5230 2027 \u5e74\u5c06\u8fbe\u5230 4.32 \u4ebf\u6fb3\u5143\u3002<\/p>\n

\u6700\u540e\uff0c\u5176\u4e2d\u6700\u5927\u7684\u5e02\u573a\uff0c\u4e5f\u662f\u4e0e\u72ac\u79d1\u52a8\u7269\u4e34\u5e8a\u7ed3\u679c\u5bc6\u5207\u76f8\u5173\u7684\u5e02\u573a\uff0c\u6709\u52a9\u4e8e\u5feb\u901f\u5411\u4eba\u7c7b\u8f6c\u5316\uff0c\u662f\u4ef7\u503c 1250 \u4ebf\u7f8e\u5143\u7684\u201c\u84dd\u5929\u201d\u4eba\u7c7b\u764c\u75c7\u4ea7\u4e1a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002 \u4f4d\u4e8e\u73c0\u65af\u7684\u4e34\u5e8a\u9636\u6bb5\u751f\u7269\u6280\u672f\u4e13\u6ce8\u4e8e\u5c06\u836f\u7269 MPL \u91cd\u65b0\u7528\u4e8e\u4eba\u7c7b\u548c\u52a8\u7269\u7684\u591a\u79cd\u9776\u5411\u6cbb\u7597\uff0c\u51e0\u9879\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u4e8e 2023 \u8d22\u5e74\u5f00\u59cb\u3002 MPL \u662f\u54fa\u4e73\u52a8\u7269\u96f7\u5e15\u9709\u7d20\u9776\u86cb\u767d (mTOR) \u901a\u8def\u7684\u65b0\u578b\u3001\u5f3a\u6548\u548c\u65e0\u6bd2\u6291\u5236\u5242\uff0c\u5b83\u662f\u5f71\u54cd\u764c\u75c7\u751f\u957f\u3001\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u751a\u81f3\u75c5\u6bd2\u6d3b\u6027\u7684\u5173\u952e\u3002 \u5168\u7403 mTOR \u6291\u5236\u5242\u76ee\u524d\u6bcf\u5e74\u8d85\u8fc7 25 \u4ebf\u7f8e\u5143\uff0835.7 \u4ebf\u6fb3\u5143\uff09\uff0cPharmAust \u7684\u76ee\u6807\u662f\u5728\u672a\u6765 MPL \u5728\u517d\u533b\u764c\u75c7\u548c\u4eba\u7c7b\u764c\u75c7\u4e2d\u7684\u5e94\u7528\u4e2d\u83b7\u5229\u3002 \u4e0e\u5316\u7597\u548c\u96f7\u5e15\u9709\u7d20\u66ff\u4ee3\u54c1\u4e0d\u540c\uff0cMPL \u5177\u6709\u65e0\u6bd2\u7279\u6027\uff0c\u53ef\u4fdd\u62a4\u4e2a\u4f53\u7684\u514d\u75ab\u7cfb\u7edf\u514d\u53d7\u7834\u574f\uff0c\u5141\u8bb8\u9ad8 MPL \u5242\u91cf\uff0c\u4ece\u800c\u5e26\u6765\u66f4\u597d\u7684\u751f\u6d3b\u8d28\u91cf\u524d\u666f\u3002 PharmAust \u58f0\u79f0\uff0c\u5b83\u7684\u6297\u764c\u7279\u6027\u8fd8\u63d0\u51fa\u4e86\u4e00\u79cd\u66f4\u4fbf\u5b9c\u4e14\u5408\u4e4e\u9053\u5fb7\u7684\u72ac\u7c7b\u5316\u7597\u66ff\u4ee3\u65b9\u6848\uff0c\u8be5\u516c\u53f8\u8fc4\u4eca\u4e3a\u6b62\u7684 2 \u671f\u8bd5\u9a8c\u6570\u636e\u8bc1\u660e\u4e86\u8fd9\u4e00\u70b9\u3002 \u91cd\u65b0\u5229\u7528 MPL \u867d\u7136\u5316\u5b66\u7597\u6cd5\u4e00\u76f4\u662f\u5bf9\u6297\u764c\u75c7\u7684\u4f20\u7edf\u65b9\u6cd5\uff0c\u4f46\u5b83\u4e5f\u9488\u5bf9\u6b63\u5e38\u7684\u5065\u5eb7\u7ec6\u80de\uff0c\u540c\u65f6\u8bd5\u56fe\u5bf9\u6297\u6709\u5bb3\u7ec6\u80de\uff0c\u635f\u5bb3\u4eba\u4f53\u7684\u514d\u75ab\u7cfb\u7edf\u3002 \u56e0\u6b64\uff0c\u5c3d\u7ba1 mTOR \u6291\u5236\u5242\u53ef\u6709\u6548\u9632\u6b62\u764c\u7ec6\u80de\u751f\u957f\u548c\u589e\u6b96\uff0c\u4f46\u5b83\u4eec\u53ef\u4ee5\u4e0e\u764c\u75c7\u540c\u65f6\u653b\u51fb\u5065\u5eb7\u7ec4\u7ec7\u3002 PharmAust \u8868\u793a\uff0cMPL \u53ef\u4ee5\u4f5c\u4e3a\u4e00\u79cd\u5173\u952e\u7684\u6297\u764c\u7597\u6cd5\uff0c\u5728\u8f83\u957f\u65f6\u95f4\u5185\u5b89\u5168\u5730\u6291\u5236\u9776\u5411\u764c\u75c7\uff0c\u5e76\u5e26\u6765\u826f\u597d\u7684\u751f\u6d3b\u8d28\u91cf\u3002 MPL \u8fd8\u4fc3\u8fdb\u81ea\u566c\uff0c\u8fd9\u6709\u52a9\u4e8e\u4fdd\u62a4\u8eab\u4f53\u7684\u5065\u5eb7\u7ec6\u80de\uff0c\u5305\u62ec\u6e05\u9664\u5782\u6b7b\u7684\u764c\u7ec6\u80de\u3002 MPL \u5177\u6709\u51e0\u4e4e\u5b8c\u5168\u65e0\u6bd2\u7684\u6027\u8d28\uff0c\u4e0e\u73b0\u6709\u7684\u80bf\u7624\u5b66\u76f8\u6bd4\u5177\u6709\u663e\u7740\u4f18\u52bf\uff0c\u5e76\u63d0\u4f9b\u795e\u7ecf\u9000\u884c\u6027\u7597\u6cd5\u3002 \u4f5c\u4e3a\u4e00\u79cd\u518d\u5229\u7528\u836f\u7269\uff0cMPL \u76ee\u524d\u5df2\u5728 38 \u4e2a\u56fd\u5bb6\u6ce8\u518c\uff0c\u5e76\u83b7\u5f97\u4e86\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u7528\u54c1\u7ba1\u7406\u5c40 (TGA) \u7684\u6279\u51c6\u3002 \u518d\u5229\u7528\u836f\u7269\u63a7\u5236\u7740\u517d\u533b\u5e02\u573a\uff0c\u5e76\u4e14\u7531\u4e8e\u4e0e\u5176\u4ed6\u836f\u7269\u76f8\u6bd4\u5177\u6709\u6210\u672c\u548c\u65f6\u95f4\u6548\u76ca\uff0c\u56e0\u6b64\u5728\u4eba\u7c7b\u4ea7\u54c1\u4e2d\u8d8a\u6765\u8d8a\u53d7\u6b22\u8fce\u3002 MPL \u4f5c\u4e3a\u4e00\u79cd\u91cd\u65b0\u5229\u7528\u7684\u836f\u7269\u6709\u7740\u79ef\u6781\u7684\u5386\u53f2\uff0c\u901a\u8fc7\u4e34\u5e8a\u8bd5\u9a8c\u5728\u4eba\u7c7b\u548c\u52a8\u7269\u4e2d\u901a\u8fc7 Zolvix\u3002… Continue reading \u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":18494,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[241],"yoast_head":"\n\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8<\/title>\n<meta name=\"description\" content=\"PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8\" \/>\n<meta property=\"og:description\" content=\"PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-01T03:40:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:55:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/PharmAust-ASX-PAA-markets-monepantel-MPL-trial-success.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/\",\"name\":\"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-08-01T03:40:18+00:00\",\"dateModified\":\"2023-08-29T17:55:03+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8","description":"PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8","og_description":"PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/","og_site_name":"smallcapsCN","article_published_time":"2022-08-01T03:40:18+00:00","article_modified_time":"2023-08-29T17:55:03+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/PharmAust-ASX-PAA-markets-monepantel-MPL-trial-success.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/","url":"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/","name":"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-08-01T03:40:18+00:00","dateModified":"2023-08-29T17:55:03+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"PharmAust (ASX: PAA) \u901a\u8fc7\u5bf9\u4e3b\u8981\u5148\u5bfc\u836f\u7269\u5019\u9009\u836f\u7269\u83ab\u5948\u592a\u5c14 (MPL) \u7684\u6d4b\u8bd5\u548c\u8bd5\u9a8c\u53d6\u5f97\u4e86\u8fd1\u671f\u7684\u79ef\u6781\u8fdb\u5c55\uff0c\u53ef\u80fd\u5f88\u5feb\u5c31\u4f1a\u4e3a\u6570\u5341\u4ebf\u6fb3\u5143\u7684\u836f\u7269\u6210\u529f\u673a\u4f1a\u6253\u5f00\u5927\u95e8\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-opens-door-billion-dollar-markets-following-mpl-trial-successes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"\u5728 MPL \u8bd5\u9a8c\u6210\u529f\u4e4b\u540e\uff0cPharmAust \u4e3a\u5341\u4ebf\u6fb3\u5143\u7684\u5e02\u573a\u6253\u5f00\u4e86\u5927\u95e8"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5570"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5570"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5570\/revisions"}],"predecessor-version":[{"id":15449,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5570\/revisions\/15449"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18494"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}